← All organizations

Elixirgen Therapeutics, Inc.

For profitWebsite ↗

Also known as: Elixirgen Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jul 1, 2023

Timeline

2010s

Jan 1, 2012
Elixirgen Therapeutics, Inc.— Founded

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

exg-5003

Phase 1 (1 own, 0 via acquisition)

exg34217

Indications

Studied for

Pancytopenia

Recent trials (3)

NCT05868499Lead sponsorPhase 1Jul 1, 2023
NCT04863131CollaboratorPhase 1/Phase 2Apr 28, 2021
NCT04211714Lead sponsorPhase 1Mar 1, 2020

Details

Founded: Baltimore, MD, US Jan 1, 2012
Last known activity: Jul 1, 2023